Apelin-13 attenuates high glucose-induced calcification of MOVAS cells by regulating MAPKs and PI3K/AKT pathways and

Pu Zhang1, Ai-Ping Wang2, Hong-Peng Yang2

  • 1Department of Cardiovascular Medicine, Taian City Central Hospital, Taian, Shandong, 271000, China; College of Veterinary Medicine, Shandong Agricultural University, Taian, Shandong 271018, China.

Insights

Apelin-13 peptide effectively inhibits high glucose-induced vascular calcification in mouse cells. It works by reducing DNA damage and regulating key signaling pathways, offering a potential new treatment for diabetes-related cardiovascular disease.

Area of Science:

  • Cardiovascular Biology
  • Cellular and Molecular Medicine
  • Endocrinology

Background:

  • Vascular calcification (VC) is a significant risk factor for cardiovascular diseases, often exacerbated by diabetes.
  • The precise mechanisms underlying diabetes-induced VC remain incompletely understood.
  • Apelin, a peptide hormone in the cardiovascular system, shows promise in inhibiting VC, but its specific role in high glucose conditions requires investigation.

Purpose of the Study:

  • To investigate the inhibitory effect of apelin-13 on high glucose-induced vascular calcification (VC) in mouse aortic vascular smooth muscle cells (MOVAS).
  • To explore the underlying molecular mechanisms by which apelin-13 exerts its protective effects against high glucose-induced VC.

Main Methods:

  • MOVAS cells were treated with high glucose and apelin-13.
  • Cell proliferation, migration, invasion, and alkaline phosphatase (ALP) activity/expression were assessed.
  • Reactive oxygen species (ROS) generation, DNA damage, and the activation of MAPKs and PI3K/AKT pathways were analyzed.
  • The role of MAPKs was further confirmed using the ERK inhibitor U0126.

Main Results:

  • Apelin-13 significantly inhibited high glucose-induced proliferation, migration, and invasion of MOVAS cells.
  • Apelin-13 attenuated high glucose-induced calcification by reducing ALP activity and expression.
  • Apelin-13 suppressed high glucose-induced DNA damage by inhibiting ROS generation.
  • Apelin-13 improved high glucose-induced dysfunction in MAPKs and PI3K/AKT signaling pathways.
  • Inhibition of ERK signaling blocked high glucose-induced calcification, highlighting the role of MAPKs.

Conclusions:

  • Apelin-13 demonstrates significant potential in attenuating high glucose-induced vascular calcification in MOVAS cells.
  • The mechanism involves the inhibition of ROS-mediated DNA damage and the regulation of MAPKs and PI3K/AKT pathways.
  • Apelin-13 represents a promising therapeutic strategy for managing high glucose-mediated vascular calcification.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.0K